Navigating Nephrolithiasis: Insights and Interventions in Kidney Stone Management
Monograph
Are you a Pharmacist? Check out the Pharmacist version of this course.
Want another way to take this test? Check out the video-based version of this course.
Course Summary
Renal calculi, commonly referred to as kidney stones, are ubiquitous and persistent causing significant duress and pain, missed work and decreased productivity, and increased utilization of healthcare resources. Despite well-documented approaches to diagnosis and management of kidney stone disease (urolithiasis), including tested methods of prevention, this remains a common malady affecting many patients. Recent literature further underscores the discrepancies in evaluation and treatment based on socioeconomic status and race. With increasing prevalence and diverse etiologies, a thorough and updated understanding of effective management and prevention is warranted for all healthcare professionals. The dynamic landscape of stone formation, diagnosis, treatment, and prevention is ever-evolving, promoting the importance of continuing education and interdisciplinary collaboration. Within this course, healthcare personnel will learn how to identify risk factors for nephrolithiasis, describe the process of diagnosing kidney stones, and understand approaches to treating and preventing kidney stones.
Course Objectives
Describe risk factors for nephrolithiasis
Describe the process of diagnosing kidney stones
Recall approaches to treating and preventing kidney stones
I. Introduction
II. Epidemiology and Etiology
1. Different types and causes of renal calculi
2. SES and racial factors
III Pathophysiology
IV. Risk Factors
V. Diagnosis
VI. Approach to Treatment
1. Medical
2. Surgical
VII. Prevention
1. Nonpharmacologic
2. Pharmacologic
VIII. OTC
IX. Summary
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in the development of this activity: L. Austin Fredrickson, MD, FACP, and Pamela Sardo, PharmD, BS. Pamela Sardo was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
Rating: 5/5
Based on the ratings of 13 customers
- Target Audience: Pharmacy Tech
- Contact Hours: 1.0 (0.1 CEUs)
- Activity Release Date: 12/12/2023
- Activity Expiration Date: 12/12/2026
- Activity Type: Knowledge
- UAN: 0669-0000-23-213-H01-T
- Topic: Disease State Management/Drug Therapy
- CeBroker Number: 20-1137652
Author:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".